Close Menu

NEW YORK (GenomeWeb) – BioMérieux said today that its first quarter revenues rose 4 percent year over year, driven by a moderate flu season and strong sales momentum in the Asia-Pacific region.

For the three months ended March 31, the company reported revenues of €632.5 million ($707.8 million), up from €587 million in the prior-year period. At constant exchange rates and scope of consolidation, revenues grew 8 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.

University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.

NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.

In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.